(Date:5/15/2008)... Texas, May 15 /PRNewswire/ -- LifeCare Holdings, ... results for the first quarter,ended March 31, 200...e increased by $6.4 million, or 7.8%, for,the thre...om $82.4 million,for the comparable period in 2007....0%, greater than the same period in 2007., The i...
(Date:5/15/2008)...VER, May 15 /PRNewswire-FirstCall/ - QLT Inc. (NAS...igned a sale and purchase agreement to,sell the la...ers and an,adjacent undeveloped parcel of land in ...losing of the transaction, QLT will enter into a,f...e its operations., "We are very pleased that our ...
(Date:5/15/2008)...ICSBURG, Pa., May 15 /PRNewswire/ -- Select Medica...or its first quarter ended March 31,2008., For t...ng revenues,increased 17.4% to $548.3 million comp... year. Income from operations decreased 9.9% to $5... quarter, prior year. Net income,decreased 47.9% t...
(Date:5/15/2008)...ON, D.C. -- May 15, 2008 -- The Society for Cardi...ay announced that it will hold its 2009 Annual Sci... Las Vegas. The focused, collegial interventional ... early March meeting time beginning in 2010. , T...e premier interventional cardiology meeting of the...
Breaking Medicine News(10 mins):Health News:LifeCare Holdings, Inc. Announces First Quarter Results 2Health News:LifeCare Holdings, Inc. Announces First Quarter Results 3Health News:LifeCare Holdings, Inc. Announces First Quarter Results 4Health News:LifeCare Holdings, Inc. Announces First Quarter Results 5Health News:LifeCare Holdings, Inc. Announces First Quarter Results 6Health News:LifeCare Holdings, Inc. Announces First Quarter Results 7Health News:LifeCare Holdings, Inc. Announces First Quarter Results 8Health News:LifeCare Holdings, Inc. Announces First Quarter Results 9Health News:QLT Inc. announces agreement for sale of real estate 2Health News:QLT Inc. announces agreement for sale of real estate 3Health News:Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008 2Health News:Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008 3Health News:Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008 4Health News:Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008 5Health News:Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008 6Health News:Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008 7Health News:Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008 8Health News:Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008 9Health News:SCAI announces 2009 annual scientific sessions in Las Vegas 2...aims a study states that post-menopausal women who...h-carbohydrate foods such as fruits and whole grai...some popular diet plans blame high-carbohydrate di...ing of obesity rates. The results come from a sev...
...nion Minister for Health and Family Welfare, annou...000 crore on the second phase of the Reproductive ...amdoss announced this package at the 49th All Indi... in Kochi yesterday. He said that the challenge in...
... result in global warming may result in biological...he world. The chemical composition of Nuttalides t... // analyzed by the researchers Richard Norris and...n of Oceanography at the University of California,...
...o protect both coral reefs and fish, according to ...the University of Exeter. The Science journal has ... at how a marine park in the Bahamas was affected ...sau Grouper. They were concerned that an increase ...
Other Medicine News:Health News:Earth Will Feel The Impact Of Global Warming 2(Date:5/15/2008)...a newly cleared device to identify the, lipid cor...sociated with complications of c...wswire/ -- InfraReDx, Inc. today,announced that ph... have,successfully used its LipiScan(TM) Coronary ...atheterization. This is the first patient in the,w...
(Date:5/15/2008)...ire-FirstCall/ -- Novavax, Inc. (Nasdaq:,NVAX) tod...he Phase I/IIa,study of its pandemic influenza vac...ts. Favorable interim results from the first phase...0 healthy adult volunteers, were,reported in Decem...vaccine,is well tolerated and immunogenic at the 1...
(Date:5/15/2008)...ual Meeting of The American Society of ...IRVINE, Calif., May 15 /- I...ay announced the presentation of updated data,from...tide (L-MTP-PE) in,patients with lung metastases a...are and often fatal bone tumor that typically affe...
(Date:5/14/2008)...rtant for cervical cancer prevention, GRAZ, Austr... an,extended follow-up study show that GlaxoSmithK...ne, CERVARIX(R) generates sustained high levels of...on cervical cancer-causing,human papillomavirus ty...ion of sustained neutralizing antibody levels obse...
Breaking Medicine Technology:First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 3IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 2IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 3IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 4IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 6CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 2CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 3CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 4CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 5CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 6Californias Historic RN to Patient Hospital Staffing Ratios Upgraded Again With New Year 8998 1Californias Historic RN to Patient Hospital Staffing Ratios Upgraded Again With New Year 8998 2Californias Historic RN to Patient Hospital Staffing Ratios Upgraded Again With New Year 8998 3Sanofi Pasteur Enters Agreement With Crucell for Next Generation Biologicals Against Rabies 8995 1Sanofi Pasteur Enters Agreement With Crucell for Next Generation Biologicals Against Rabies 8995 2Sanofi Pasteur Enters Agreement With Crucell for Next Generation Biologicals Against Rabies 8995 3Sanofi Pasteur Enters Agreement With Crucell for Next Generation Biologicals Against Rabies 8995 4Exelixis Announces January 10 Webcast of Presentation at the 26th Annual JPMorgan Healthcare Conference 2415 1Nektar Therapeutics President and CEO Howard W Robin to Present At JPMorgan 26th Annual Healthcare Conference 2412 1...opean Association for the Study,of the Liver, PRIN...sset,announced today that presentations of preclin...atitis B (HBV) and PSI-6130, the,parent molecule o...ll be made during the 42nd Annual Meeting of the E...SL) being held in,Barcelona, Spain from April 11-1...
...d at ECCMID/ICC, MUNICH, Germany, April 03, 2007 /...ed results from two studies showing the,improved p...vitro,when tested with a common wetting agent (pol...ity of oritavancin against S.,pneumoniae in a mous...copeptide antibiotic, is Targanta,s lead product c...
Other Medicine Technology:Pharmasset Announces Clevudine and Hepatitis C Presentations at,EASL 2Pharmasset Announces Clevudine and Hepatitis C Presentations at,EASL 3Pharmasset Announces Clevudine and Hepatitis C Presentations at,EASL 4Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 2Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 3Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 4Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 5Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 6Near point card/newspaper 8 to 48 point type 5 1/2" X 8".
Near and far chart set provides letter and number matrix for testing and accommodative vision training. Set includes 1-8 1/2 X 11 chart on white card with black print and 2-3X5 laminated white card w
...mmon print sizes, from newspaper headline to textb...e examiner a starting point to determine acuity. T...tyrene for increased contrast. It features sizes f...ude Jaeger, M notation, lower case point size, siz...
...signed by James Lebensohn, MD and provides a full ...bers and OX symbols. Optotypes include 20/80, 20/4...0/30, 20/25, and 20/20. Notation equivalents inclu...point size and visual efficiency percentages. Card...
Medicine Products: